The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues.

Sandra Abou Kassm, Wadih Naja, Ramzi Haddad, Antoine Pelissolo

Current psychiatry reports 2021 Mar 03

filter terms:

This paper seeks to describe anxiety's different symptomatologic presentations in Parkinson's disease (PD), its longitudinal course and predictors, as well as its motor and non-motor correlates. It also reviews the available screening tools and different treatment modalities. In PD, longitudinal predictors of anxiety are mostly non-motor non-dopaminergic symptoms. The longitudinal course of anxiety is mainly a stable one. The Parkinson Anxiety Scale and the Geriatric Anxiety Scale are the 2 recommended screening tools. A third of PD patients suffer from an anxiety disorder at any time point. It can precede or follow PD motor symptoms. Anxiety is associated with demographic, disease-related motor and non-motor features. There is a lack of studies evaluating psychotropic treatment of anxiety in PD. Adjustment of dopaminergic treatment is indicated when anxiety is associated with motor fluctuations. DBS can be useful as well as CBT and body-mind interventions.

Citation

Sandra Abou Kassm, Wadih Naja, Ramzi Haddad, Antoine Pelissolo. The Relationship Between Anxiety Disorders and Parkinson's Disease: Clinical and Therapeutic Issues. Current psychiatry reports. 2021 Mar 03;23(4):20